Press Releases

WASHINGTON, Aug. 14, 2019 /PRNewswire/ -- The Alliance to Prevent Legionnaires' Disease, a national organization dedicated to reducing the occurrence of Legionnaires' Disease by promoting public research, education, best practices for water management, and advocating for comprehensive policies to combat and investigate this preventable disease, today issued the f

BOSTON, Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercializatio

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today reported financial results for its first quarter ended June 30, 2019 and provided an update on recent developments.Company UpdatesAethlon Medical, Inc. (Comp

SARASOTA, Fla., Aug. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company which was granted FDA clearance for its Intravaginal Culture System, INVOcell®, today announced financial results for the second quarter of 2019, ended June 30, 2019.

COSTA MESA, Calif., Aug. 14, 2019 /PRNewswire/ -- Based on the world's largest functional brain imaging database, Daniel Amen, MD will present a completely new way to think about and treat issues, such as anxiety, depression, bipolar disorders, ADHD, addictions, OCD, PTSD, schizophrenia, and even personality disorders. In his presentation

HOUSTON, Aug. 14, 2019 /PRNewswire/ -- US Med-Equip, which partners with top hospitals across the nation to provide the highest quality movable medical equipment, is again named as one of the nation's fastest-growing private companies in Inc. 

PARAMUS, N.J., Aug. 14, 2019 /PRNewswire/ -- DON Recovery Services (DRS) has chosen to  implement the MedicsCloud Addiction Medicine Clinical and Financial Suite from Advanced Data Systems (

WARRINGTON, Pa., Aug. 14, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the second quarter ended June 30,

MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced second quarter results and provided a corporate and clinical update.  

NASHVILLE, Tenn., Aug. 14, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today announced second quarter 2019 financial results with net revenues of $11.6 million, up 14% over the prior year quarter. Year-to-date net revenues were